Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21039410 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Conditions: Sezary Syndrome;   Pruritus
Interventions: Drug: Aprepitant;   Drug: Placebo
2 Active, not recruiting Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Aprepitant and placebo;   Drug: desloratadine and placebo

Study has passed its completion date and status has not been verified in more than two years.